{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:46:27Z","timestamp":1781790387524,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T00:00:00Z","timestamp":1746230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mabibo Traditional Medicine Research Centre (NIMR Mabibo Centre) through a sub-award from Malaria Atlas Project in Perth, Australia","award":["RES-62388\/ CTR-18258"],"award-info":[{"award-number":["RES-62388\/ CTR-18258"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>East Africa continues to bear a significant share of the global malaria burden, despite its commitment to the malaria elimination goal of 2030. Furthermore, reported variations in adherence to anti-malarials hamper the regional effort in malaria elimination. Moreover, the region has no comprehensive and comparable adherence estimates for policymakers to set priorities, target control strategies, and evaluate the effectiveness of interventions. Hence, this systematic review synthesized the regional adherence estimate for East Africa.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Authors searched articles from PubMed, Science Direct, CINHAL, Scopus, and Google Scholar. Two authors independently assessed retrieved studies for eligibility and risk of bias, then the adherence rate was pooled using the random effect model implemented in STATA. Publication bias was assessed using a funnel plot symmetry and the Egger test. Subgroup analysis was performed to explore the effect of the national and types of regimens on the overall estimate. Qualitative analysis was applied to explain factors that influence adherence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 29 studies with 15 927 participants were included. The overall adherence rate was 70.30% (95% CI 61.93\u201378.67; 29 studies; I<jats:sup>2<\/jats:sup>\u2009=\u200999.76%), with the highest level reported in Rwanda (100%, 95% CI 97.28\u2013100.00) and lowest in Tanzania (6.99%, 95% CI 0.2.81\u201311.17). Furthermore, adherence was high for chloroquine plus sulfadoxine-pyrimethamine (96.27%, 93.87\u201398.66; one study). Recalling correct instructions and taking the first dose at the health facility had a positive influence on patient adherence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>On average, about three-quarters of malaria patients in East Africa adhere to their medications. In light of these findings, further interventional studies are needed to address low adherence to anti-malarials in the region. Moreover, adherence studies with the appropriate method of measurement are still needed to obtain a robust generalizable estimate in East Africa.<\/jats:p>\n            <jats:p>\n              <jats:italic>Trial registration<\/jats:italic> This review was registered at PROSPERO with the registration ID CRD42023410048.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12936-025-05303-y","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T09:35:04Z","timestamp":1746264904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adherence to anti-malarials among patients diagnosed with malaria in East Africa: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Jackline D.","family":"Nkoma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan F.","family":"Rumisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamisi S.","family":"Japhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel L.","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,3]]},"reference":[{"key":"5303_CR1","volume-title":"World malaria report 2024: addressing inequity in the global malaria response","author":"WHO","year":"2024","unstructured":"WHO. World malaria report 2024: addressing inequity in the global malaria response. Geneva: World Health Organization; 2024."},{"key":"5303_CR2","volume-title":"Global technical strategy for malaria 2016\u20132030, 2021 update","author":"WHO","year":"2021","unstructured":"WHO. Global technical strategy for malaria 2016\u20132030, 2021 update. Geneva: World Health Organization; 2021."},{"key":"5303_CR3","unstructured":"WHO. High burden to high impact: a targeted malaria response. WHO\/CDS\/GMP\/2018. Geneva: World Health Organization."},{"key":"5303_CR4","first-page":"2025","volume":"13","author":"HA Pasquale","year":"2020","unstructured":"Pasquale HA. South Sudan\u2019s New National Malaria Strategic Plan 2021\u20132025 is a game changer. South Sudan Med J. 2020;13:2025.","journal-title":"South Sudan Med J"},{"key":"5303_CR5","volume-title":"Rwanda malaria strategic plan 2020\u20132024","author":"Rwanda Ministry of Health","year":"2020","unstructured":"Rwanda Ministry of Health. Rwanda malaria strategic plan 2020\u20132024. Kigali: Republic of Rwanda; 2020."},{"key":"5303_CR6","unstructured":"United Republic of Tanzania, Ministry of Health, Community Development, Gender, Elderly and Children. Natl Malar Strateg Plan 2021\u20132025. Tanzania, Dodoma; 2021."},{"key":"5303_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2334-12-143","volume":"12","author":"EO Onyango","year":"2012","unstructured":"Onyango EO, Ayodo G, Watsierah CA, Were T, Okumu W, Anyona SB. Factors associated with non-adherence to artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya. BMC Infect Dis. 2012;12:43.","journal-title":"BMC Infect Dis"},{"key":"5303_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13031-022-00463-z","volume":"16","author":"IO Idris","year":"2022","unstructured":"Idris IO, Ayeni GO II, Suna-Odunsi AB, AdebisiYA OJ. Factors influencing severity of recurrent malaria in a conflict-affected state of South Sudan: an unmatched case-control study. Confl Health. 2022;16:34.","journal-title":"Confl Health"},{"key":"5303_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016982","volume":"8","author":"RL Cutler","year":"2018","unstructured":"Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8: e016982.","journal-title":"BMJ Open"},{"key":"5303_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134061","volume":"10","author":"JA Walldorf","year":"2015","unstructured":"Walldorf JA, Cohee LM, Coalson JE, Bauleni A, Nkanaunena K, Kapito-tembo A, et al. School-age children are a reservoir of malaria infection in Malawi. PLoS ONE. 2015;10: e013406.","journal-title":"PLoS ONE"},{"key":"5303_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4269\/ajtmh.15-0420","volume":"94","author":"I Saran","year":"2016","unstructured":"Saran I, Yavuz E, Kasozi H, Cohen J. Can rapid diagnostic testing for malaria increase adherence to artemether-lumefantrine?: a randomized controlled trial in Uganda. Am J Trop Med Hyg. 2016;94:857\u201367.","journal-title":"Am J Trop Med Hyg"},{"key":"5303_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12936-015-0933-7","volume":"14","author":"S Gerstl","year":"2015","unstructured":"Gerstl S, Namagana A, Palacios L, Mweshi F, Aprile S, Lima A. High adherence to malaria treatment: promising results of an adherence study in South Kivu, Democratic Republic of the Congo. Malar J. 2015;14:414.","journal-title":"Malar J"},{"key":"5303_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12936-015-0602-x","volume":"14","author":"K Bruxvoort","year":"2015","unstructured":"Bruxvoort K, Kalolella A, Cairns M, Festo C, Kenani M, Lyaruu P, et al. Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy? Malar J. 2015;14:87.","journal-title":"Malar J"},{"key":"5303_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349: g7647.","journal-title":"BMJ"},{"key":"5303_CR15","first-page":"372","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372.","journal-title":"BMJ"},{"key":"5303_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"5303_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JAC Sterne","year":"2011","unstructured":"Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised. BMJ. 2011;343: d4002.","journal-title":"BMJ"},{"key":"5303_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method. Biometrics. 2000;56:455\u201363.","journal-title":"Biometrics"},{"key":"5303_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/1475-2875-13-267","volume":"13","author":"O Minzi","year":"2014","unstructured":"Minzi O, Maige S, Sasi P, Ngasala B. Adherence to artemether-lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania. Malar J. 2014;13:267.","journal-title":"Malar J"},{"key":"5303_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jdeveco.2018.04.008","volume":"134","author":"J Cohen","year":"2018","unstructured":"Cohen J, Saran I. The impact of packaging and messaging on adherence to malaria treatment: evidence from a randomized controlled trial in Uganda. J Dev Econ. 2018;134:68\u201395.","journal-title":"J Dev Econ"},{"key":"5303_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12936-015-0645-z","volume":"14","author":"GR Gore-Langton","year":"2015","unstructured":"Gore-Langton GR, Alenwi N, Mungai J, Erupe NI, Eves K, Kimwana FN, et al. Patient adherence to prescribed artemisinin-based combination therapy in Garissa County, Kenya, after three years of health care in a conflict setting. Malar J. 2015;14:125.","journal-title":"Malar J"},{"key":"5303_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1161\/01.HYP.2.6.757","volume":"2","author":"RB Haynes","year":"1980","unstructured":"Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertens. 1980;2:757\u201364.","journal-title":"Hypertens"},{"key":"5303_CR23","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/pds.4334","volume":"26","author":"WF Gellad","year":"2017","unstructured":"Gellad WF, Thorpe CT, Steiner JF, Voils CI. The myths of medication adherence. Pharmacoepidemiol Drug Saf. 2017;26:1437\u201341.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"5303_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","volume":"5","author":"MJ Stirratt","year":"2015","unstructured":"Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5:470\u201382.","journal-title":"Transl Behav Med"},{"key":"5303_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11904-009-0024-x","volume":"6","author":"IB Wilson","year":"2009","unstructured":"Wilson IB, Carter AE, Berg KM. Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Curr HIV\/AIDS Rep. 2009;6:177\u201386.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"5303_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10461-006-9121-7","volume":"10","author":"DR Bangsberg","year":"2006","unstructured":"Bangsberg DR. Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: the past, the present, and the future. AIDS Behav. 2006;10:249\u201351.","journal-title":"AIDS Behav"},{"key":"5303_CR27","doi-asserted-by":"publisher","first-page":"844","DOI":"10.4269\/ajtmh.14-0126","volume":"91","author":"K Bruxvoort","year":"2014","unstructured":"Bruxvoort K, Festo C, Kalolella A, Cairns M, Lyaruu P, Kenani M, et al. Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherence. Am J Trop Med Hyg. 2014;91:844\u201353.","journal-title":"Am J Trop Med Hyg"},{"key":"5303_CR28","doi-asserted-by":"publisher","first-page":"7465254","DOI":"10.1155\/2018\/7465254","volume":"2018","author":"A Afaya","year":"2018","unstructured":"Afaya A, Salia SM, Adatara P, Afaya RA, Suglo S, Japiong M. Patients\u2019 knowledge of artemisinin-based combination therapy treatment and its impact on patient adherence. J Trop Med. 2018;2018:7465254.","journal-title":"J Trop Med"},{"key":"5303_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1475-2875-10-99","volume":"10","author":"CA Watsierah","year":"2011","unstructured":"Watsierah CA, Jura WGZO, Raballah E, Kaseje D, Abong\u2019o B, Ouma C. Knowledge and behaviour as determinants of anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya. Malar J. 2011;10:99.","journal-title":"Malar J"},{"key":"5303_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12936-017-2164-6","volume":"17","author":"C Jones","year":"2018","unstructured":"Jones C, Talisuna AO, Snow RW, Zurovac D. We were being treated like the Queen\u201d: understanding trial factors influencing high paediatric malaria treatment adherence in western Kenya. Malar J. 2018;17:8.","journal-title":"Malar J"},{"key":"5303_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130305","volume":"10","author":"B Wasunna","year":"2015","unstructured":"Wasunna B, Okiro EA, Webster J, Todd J, Snow RW, Jones C. The impact of a community awareness strategy on caregiver treatment seeking behaviour and use of artemether-lumefantrine for febrile children in rural Kenya. PLoS ONE. 2015;10: e013030.","journal-title":"PLoS ONE"},{"key":"5303_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12936-023-04725-w","volume":"22","author":"P Mehdipour","year":"2023","unstructured":"Mehdipour P, Rajasekhar M, Dini S, Zaloumis S, Abreha T, Adam I, et al. Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis. Malar J. 2023;22:306.","journal-title":"Malar J"},{"key":"5303_CR33","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2352-3018(20)30307-6","volume":"8","author":"JE Haberer","year":"2021","unstructured":"Haberer JE, Bukusi EA, Mugo NR, Pyra M, Kiptinness C, Oware K, et al. Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial. Lancet HIV. 2021;8:e130\u20137.","journal-title":"Lancet HIV"},{"key":"5303_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12911-017-0413-9","volume":"17","author":"N Georgette","year":"2017","unstructured":"Georgette N, Siedner MJ, Petty CR, Zanoni BC, Carpenter S, Haberer JE. Impact of a clinical program using weekly Short Message Service (SMS) on antiretroviral therapy adherence support in South Africa: a retrospective cohort study. BMC Med Inform Decis Mak. 2017;17:18.","journal-title":"BMC Med Inform Decis Mak"},{"key":"5303_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1186\/1471-2458-13-987","volume":"13","author":"F Kinyua","year":"2013","unstructured":"Kinyua F, Kiptoo M, Kikuvi G, Mutai J, Meyers AFA, Muiruri P, et al. Perceptions of HIV infected patients on the use of cell phone as a tool to support their antiretroviral adherence; a cross-sectional study in a large referral hospital in Kenya. BMC Pub Health. 2013;13:987.","journal-title":"BMC Pub Health"},{"key":"5303_CR36","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.2105\/AJPH.2017.304089","volume":"107","author":"S Linnemayr","year":"2017","unstructured":"Linnemayr S, Huang H, Luoto J, Kambugu A, Thirumurthy H, Haberer JE, et al. Text messaging for improving antiretroviral therapy adherence: no effects after 1 year in a randomized controlled trial among adolescents and young adults. Am J Public Health. 2017;107:1944\u201350.","journal-title":"Am J Public Health"},{"key":"5303_CR37","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/S0140-6736(10)61997-6","volume":"376","author":"RT Lester","year":"2010","unstructured":"Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010;376:1838\u201345.","journal-title":"Lancet"},{"key":"5303_CR38","first-page":"640","volume":"96","author":"A Bhargava","year":"2018","unstructured":"Bhargava A, Boulle A, Reif L, Hilderbrand K, Benatar SR. Improving treatment adherence in resource-poor settings. Bull World Health Organ. 2018;96:640\u20136.","journal-title":"Bull World Health Organ"},{"key":"5303_CR39","first-page":"12","volume":"74","author":"BK Ngwatu","year":"2017","unstructured":"Ngwatu BK, Nsanzimana S, Haberer JE, Mutabazi V, Ndagijimana A. Enhancing adherence to antiretroviral therapy through improved packaging: a pilot program in Rwanda. Rwanda Med J. 2017;74:12\u20138.","journal-title":"Rwanda Med J"},{"key":"5303_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2763","volume":"339","author":"J Achan","year":"2009","unstructured":"Achan J, Tibenderana JK, Kyabayinze D, Mangen W, Kamya MR, Dorsey G, et al. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ. 2009;339: b2763.","journal-title":"BMJ"},{"key":"5303_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12936-017-1982-x","volume":"16","author":"AS Ali","year":"2017","unstructured":"Ali AS, Thawer NG, Khatib B, Amier HH, Shija J, Msellem M, et al. Artemisinin combination therapy mass drug administration in a setting of low malaria endemicity: programmatic coverage and adherence during an observational study in Zanzibar. Malar J. 2017;16:332.","journal-title":"Malar J"},{"key":"5303_CR42","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/j.1365-3156.2004.01291.x","volume":"9","author":"AA Amin","year":"2004","unstructured":"Amin AA, Hughes DA, Marsh V, Abuya TO, Kokwaro GO, Winstanley PA, et al. The difference between effectiveness and efficacy of antimalarial drugs in Kenya. Trop Med Int Health. 2004;9:967\u201374.","journal-title":"Trop Med Int Health"},{"key":"5303_CR43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12936-015-0664-9","volume":"14","author":"R Baiden","year":"2015","unstructured":"Baiden R, Oduro A, Halidou T, Gyapong M, Sie A, Macete E, et al. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim\u00ae (dihydroartemisinin\/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania. Malar J. 2015;14:160.","journal-title":"Malar J"},{"key":"5303_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-023-04824-8","volume":"23","author":"C Bawate","year":"2024","unstructured":"Bawate C, Callender-Carter ST, Guyah B, Ouma C. Factors influencing patients\u2019 adherence to malaria artemisinin-based combination therapy in Kamuli District Uganda. Malar J. 2024;23:1.","journal-title":"Malar J"},{"key":"5303_CR45","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1365-3156.2009.02289.x","volume":"14","author":"N Beer","year":"2009","unstructured":"Beer N, Ali AS, Rotllant G, Abass AK, Omari RS, Al-mafazy AH, et al. Adherence to artesunate-amodiaquine combination therapy for uncomplicated malaria in children in Zanzibar Tanzania. Trop Med Int Health. 2009;14:766\u201374.","journal-title":"Trop Med Int Health"},{"key":"5303_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134275","volume":"10","author":"K Bruxvoort","year":"2015","unstructured":"Bruxvoort K, Festo C, Cairns M, Kalolella A, Mayaya F, Kachur SP, et al. Measuring patient adherence to malaria treatment: a comparison of results from self-report and a customised electronic monitoring device. PLoS ONE. 2015;10: e0134275.","journal-title":"PLoS ONE"},{"key":"5303_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1475-2875-11-83","volume":"11","author":"JL Cohen","year":"2012","unstructured":"Cohen JL, Yavuz E, Morris A, Arkedis J, Sabot O. Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda. Malar J. 2012;11:83.","journal-title":"Malar J"},{"key":"5303_CR48","doi-asserted-by":"publisher","first-page":"525","DOI":"10.4269\/ajtmh.2004.71.525","volume":"71","author":"C Fogg","year":"2004","unstructured":"Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, et al. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg. 2004;71:525\u201330.","journal-title":"Am J Trop Med Hyg"},{"key":"5303_CR49","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4269\/ajtmh.2004.71.715","volume":"71","author":"SP Kachur","year":"2004","unstructured":"Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, Bloland PB. Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am J Trop Med Hyg. 2004;71:715\u201322.","journal-title":"Am J Trop Med Hyg"},{"key":"5303_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060481","volume":"8","author":"JN Kalyango","year":"2013","unstructured":"Kalyango JN, Rutebemberwa E, Karamagi C, Mworozi E, Ssali S, Alfven T, et al. High adherence to antimalarials and antibiotics under integrated community case management of illness in children less than five years in eastern Uganda. PLoS ONE. 2013;8: e60481.","journal-title":"PLoS ONE"},{"key":"5303_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1475-2875-5-40","volume":"5","author":"JH Kolaczinski","year":"2006","unstructured":"Kolaczinski JH, Ojok N, Opwonya J, Meek S, Collins A. Adherence of community caretakers of children to pre-packaged antimalarial medicines (HOMAPAK\u00ae) among internally displaced people in Gulu district Uganda. Malar J. 2006;5:40.","journal-title":"Malar J"},{"key":"5303_CR52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1475-2875-10-281","volume":"10","author":"H Lawford","year":"2011","unstructured":"Lawford H, Zurovac D, O\u2019Reilly L, Hoibak S, Cowley A, Munga S, et al. Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts Kenya. Malar J. 2011;10:281.","journal-title":"Malar J"},{"key":"5303_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12916-018-1202-8","volume":"16","author":"U Morris","year":"2018","unstructured":"Morris U, Msellem MI, Mkali H, Islam A, Aydin-Schmidt B, Jovel I, et al. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission. BMC Med. 2018;16:215.","journal-title":"BMC Med"},{"key":"5303_CR54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12936-016-1542-9","volume":"15","author":"EN Mutua","year":"2016","unstructured":"Mutua EN, Bukachi SA, Bett BK, Estambale BA, Nyamongo IK. Lay knowledge and management of malaria in Baringo county Kenya. Malar J. 2016;15:486.","journal-title":"Malar J"},{"key":"5303_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1365-3156.2002.00858.x","volume":"7","author":"N Nshakira","year":"2002","unstructured":"Nshakira N, Kristensen M, Ssali F, Whyte SR. Appropriate treatment of malaria? Use of antimalarial drugs for children\u2019s fevers in district medical units, drug shops and homes in eastern Uganda. Trop Med Int Health. 2002;7:309\u201316.","journal-title":"Trop Med Int Health"},{"key":"5303_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2334-12-143","volume":"12","author":"EO Onyango","year":"2012","unstructured":"Onyango EO, Ayodo G, Watsierah CA, Were T, Okumu W, Anyona SB, et al. Factors associated with non-adherence to artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya. BMC Infect Dis. 2012;12:143.","journal-title":"BMC Infect Dis"},{"key":"5303_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12936-017-1702-6","volume":"16","author":"AO Talisuna","year":"2017","unstructured":"Talisuna AO, Oburu A, Githinji S, Malinga J, Amboko B, Bejon P, et al. Efficacy of text-message reminders on paediatric malaria treatment adherence and their post-treatment return to health facilities in Kenya: a randomized controlled trial. Malar J. 2017;16:46.","journal-title":"Malar J"},{"key":"5303_CR58","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/1475-2875-9-206","volume":"9","author":"M Twagirumukiza","year":"2010","unstructured":"Twagirumukiza M, Kayumba PC, Kips JG, Vrijens B, Stichele RV, Vervaet C, et al. Evaluation of medication adherence methods in the treatment of malaria in Rwandan infants. Malar J. 2010;9:206.","journal-title":"Malar J"},{"key":"5303_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113311","volume":"9","author":"A Yeka","year":"2014","unstructured":"Yeka A, Lameyre V, Afizi K, Fredrick M, Lukwago R, Kamya MR. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children. PLoS ONE. 2014;9: e113311.","journal-title":"PLoS ONE"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05303-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05303-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05303-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T11:02:57Z","timestamp":1746270177000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05303-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,3]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5303"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05303-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,3]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}